Skip to main content
. 2017 Jan-Mar;20(1):76–82. doi: 10.4103/0971-9784.197841

Table 2.

Preoperative factors

Group P

Controls (n=99), n (%) Cases (n=21), n (%)
Diagnosis
 Valvular heart disease 44 (44.4) 9 (42.9) 0.894
 Coronary artery disease 36 (36.4) 11 (52.4) 0.172
 Acyanotic congenital heart disease 10 (10.1) 1 (4.8) 0.723**
 Congenital cyanotic heart disease 2 (2.0) 0 0.778**
 Vascular surgery 7 (7.1) 0 0.457**
Drug abuse 2 (2.0) 1 (4.8) 1.000**
Alcoholic 12 (12.1) 4 (19.0) 0.621**
HTN 27 (27.3) 15 (71.4) <0.0001
Diabetes 15 (15.2) 8 (38.1) 0.034**
Thyroid disease 4 (4) 0 0.789**
History of cardiac surgery 9 (9.1) 2 (9.5) 1.000**
History of stroke 5 (5.1) 2 (9.5) 0.778**
Vascular disease 4 (4.0) 1 (4.8) 1.000**
Depression 1 (1.0) 0 1.000**
Renal dysfunction 3 (3.0) 4 (19.0) 0.020**
LVEF<30% 8 (8.1) 0 0.386**
Atrial fibrillation 17 (17.2) 1 (4.8) 0.267**
Emergency surgery 7 (7.1) 1 (4.8) 1.000**
Cardiogenic shock 2 (2) 0 1.000**
Severe PAH% 8 (8.1) 1 (4.8) 0.945**
NYHA 3 or 4 36 (36.4) 14 (66.7) 0.011
Premedication 88 (88.9) 18 (85.7) 0.970**
Carotid artery disease 5 (5.1) 7 (33.3) <0.0001

**Yate’s corrected Chi-square test. LVEF: Left ventricular ejection fraction, PAH: Pulmonary artery hypertension, NYHA: New York Heart Association, HTN: Hypertension